Diazoxide and cyclosporin A protect primary cholinergic neurons against beta-amyloid (1-42)-induced cytotoxicity

Neurol Res. 2013 Jun;35(5):529-36. doi: 10.1179/1743132813Y.0000000202. Epub 2013 Apr 16.

Abstract

Objective: Activation of mitochondrial (MitoKATP) channels was found to protect against anoxic and chemical stress in brain. This present study sought to investigate the ability of diazoxide and cyclosporin A to antagonize cytotoxicity induced by beta-amyloid peptide (A-beta1-42) in cultured rat primary basal forebrain cholinergic neurons.

Methods: Cytotoxicity was induced by A-beta1-42 (2 μM) in the presence of either diazoxide (500 μM), a selective opener of the mitochondrial ATP-sensitive potassium channel (MitoKATP), or cyclosporin A (20 μM), an inhibitor of the mitochondrial permeability transition pore (MTP), or the combination of both the reagents. We determined cell morphology and cell viability using MTT assay and expression levels of anti-apoptotic protein (Bcl-2), pro-apoptotic proteins (Bax, cytochrome C, caspase-3 and cleaved caspase-3) using Western blotting at 24 hours and 72 hours.

Results: Cell viability decreased markedly after exposure to A-beta1-42 for 72 hours with a decrease in the expression of Bcl-2 protein and cytochrome C and an increase in the caspase-3 and cleaved caspase-3 levels. Both diazoxide and cyclosporin A exerted significant protective effects on cell viability by ameliorating the decrease in Bcl-2 and the increase in cytochrome c and caspase-3 activity induced by A-beta1-42. The combination of both the reagents had a greater protective effect than either one alone.

Conclusions: The present research demonstrates that activation of MitoKATP channels independently or in combination with inhibitors of the MTP can elicit a protective effect against primary cholinergic neuron cytotoxicity induced by A-beta1-42. These findings suggest new mitochondrial targets for the development of therapeutic agents against A-beta-induced cytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Apoptosis Regulatory Proteins / metabolism*
  • Cell Survival / drug effects*
  • Cholinergic Neurons / cytology
  • Cholinergic Neurons / drug effects*
  • Cholinergic Neurons / metabolism
  • Cyclosporine / pharmacology
  • Diazoxide / pharmacology
  • Drug Synergism
  • Gene Expression / drug effects
  • Mitochondrial Membrane Transport Proteins / antagonists & inhibitors
  • Mitochondrial Permeability Transition Pore
  • Neuroprotective Agents / pharmacology*
  • Peptide Fragments / antagonists & inhibitors*
  • Peptide Fragments / toxicity*
  • Potassium Channels / agonists
  • Primary Cell Culture
  • Prosencephalon / drug effects
  • Prosencephalon / metabolism
  • Rats
  • bcl-2-Associated X Protein / metabolism

Substances

  • Amyloid beta-Peptides
  • Apoptosis Regulatory Proteins
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Neuroprotective Agents
  • Peptide Fragments
  • Potassium Channels
  • amyloid beta-protein (1-42)
  • bcl-2-Associated X Protein
  • mitochondrial K(ATP) channel
  • Cyclosporine
  • Diazoxide